Eric Harold Yecies

Eric Harold Yecies (senior executive) discloses dealings in LifeMD, Inc. to SEC (Form 4). The record holds 11 filings, for trades running from 19 May 2021 to 22 August 2025.

Both buying and selling appear: 4 purchases worth €153k, against 1 sale worth €158k. The net balance comes to €4,952 on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 share grants and 1 option exercise. 2025 to date brings no purchases and 1 sale.

In size, the median ticket on the buying side is €27k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 26 August 2025, the filings show a share grant in LifeMD, Inc. The last insider purchase was made public on 14 June 2023, 1,222 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.